Efficacy of Probiotics in Management of Celiac Disease

Basit Ali1, Ali Raza Khan2

  • 1Medicine, Nishtar Medical Univeristy, Multan, PAK.

Cureus
|March 28, 2022
PubMed

Insights

Probiotics significantly reduce diarrhea in children with celiac disease. This intervention improves quality of life and aids in managing the condition when combined with a gluten-free diet.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Pediatrics

Background:

  • Celiac disease management primarily relies on a strict gluten-free diet.
  • Diarrhea is a common and debilitating symptom in pediatric celiac disease.
  • The role of probiotics in celiac disease management requires further investigation.

Purpose of the Study:

  • To evaluate the efficacy of probiotics in managing celiac disease in children.
  • To assess the impact of probiotics on reducing stool frequency.
  • To determine if probiotics can improve the quality of life for celiac patients.

Main Methods:

  • A cross-sectional study involving 170 children diagnosed with celiac disease.
  • Participants were divided into two groups: gluten-free diet alone (Group A) and gluten-free diet with probiotics (Group B).
  • Stool frequency was measured over 28 days, with statistical analysis using the Chi-square test.

Main Results:

  • Group B (probiotics + gluten-free diet) showed a significant reduction in stool frequency (90.59%) compared to Group A (gluten-free diet alone, 63.53%).
  • The Chi-square test yielded a p-value of 0.000027, indicating a statistically significant difference between the groups.
  • Probiotic supplementation demonstrated a marked decrease in diarrhea episodes.

Conclusions:

  • Probiotics are highly effective in reducing diarrhea associated with celiac disease.
  • Incorporating probiotics into the treatment regimen can enhance the quality of life for children with celiac disease.
  • Probiotics play a crucial role in the comprehensive management of pediatric celiac disease.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
443
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
357
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
216
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
153
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
328
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
231